Physician profile
Sumon Roy
NPI 1447601109
$44,828.21
in general payments reported to CMS, 2019-2025
22 companies · $7,346 in 2025
The $7,346 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.76 · 2022: $8,708 · 2023: $24K · 2024: $4,626 · 2025: $7,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $21K · Food and Beverage: $9,247 · Travel and Lodging: $5,842 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $21,000.00 |
| Food and Beverage | $9,247.24 |
| Travel and Lodging | $5,841.68 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $36,503.41 | 2022-2025 | Corevalve Evolut R, Cg Future |
| Abiomed | $2,433.31 | 2022-2025 | Impella |
| Abbott Laboratories | $1,872.66 | 2023-2025 | Triclip, Amplatzer, Mitraclip |
| Edwards Lifesciences Corporation | $1,451.81 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $413.48 | 2024-2025 | Wegovy, Ozempic |
| Novartis Pharmaceuticals Corporation | $385.28 | 2023-2025 | |
| Boston Scientific Corporation | $342.37 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Pfizer INC. | $273.31 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $187.44 | 2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $169.44 | 2025 | Eliquis, Camzyos |
| Shockwave Medical, INC | $151.41 | 2022 | |
| Alnylam Pharmaceuticals INC. | $142.96 | 2024-2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $117.60 | 2022 | |
| Livanova USA, INC. | $105.08 | 2023 | Lifesparc |
| Amgen INC. | $59.93 | 2025 | Repatha |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $55.57 | 2025 | Metacross Otw, Tr Band |
| W. L. Gore & Associates, INC. | $42.82 | 2025 | Gore Cardioform Septal Occluder |
| Regeneron Healthcare Solutions, INC. | $26.75 | 2025 | Evkeeza |
| Recor Medical INC | $24.97 | 2025 | Paradise Ultrasound Renal Denervation System |
| Bayer Healthcare Pharmaceuticals INC. | $24.69 | 2025 | |
| Chiesi USA, INC. | $22.93 | 2025 | Cleviprex, Kengreal |
| Scpharmaceuticals INC. | $20.99 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sumon Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.